Metropolitan Life Insurance Company (MetLife)’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,394
| Closed | -$47.1K | – | 165 |
|
|
2024
Q1 | $47.1K | Hold |
1,394
| – | – | ﹤0.01% | 1436 |
|
|
2023
Q4 | $44K | Hold |
1,394
| – | – | ﹤0.01% | 1515 |
|
|
2023
Q3 | $35.6K | Hold |
1,394
| – | – | ﹤0.01% | 1582 |
|
|
2023
Q2 | $40K | Hold |
1,394
| – | – | ﹤0.01% | 1563 |
|
|
2023
Q1 | $33.4K | Hold |
1,394
| – | – | ﹤0.01% | 1613 |
|
|
2022
Q4 | $23.6K | Hold |
1,394
| – | – | ﹤0.01% | 1922 |
|
|
2022
Q3 | $20.7K | Hold |
1,394
| – | – | ﹤0.01% | 2015 |
|
|
2022
Q2 | $21.9K | Hold |
1,394
| – | – | ﹤0.01% | 2010 |
|
|
2022
Q1 | $37.6K | Sell |
1,394
-4,915
| -78% | -$133K | ﹤0.01% | 1749 |
|
|
2021
Q4 | $233K | Hold |
6,309
| – | – | ﹤0.01% | 1922 |
|
|
2021
Q3 | $301K | Buy |
6,309
+62
| +1% | +$2.96K | ﹤0.01% | 1764 |
|
|
2021
Q2 | $211K | Hold |
6,247
| – | – | ﹤0.01% | 2103 |
|
|
2021
Q1 | $258K | Hold |
6,247
| – | – | ﹤0.01% | 1838 |
|
|
2020
Q4 | $271K | Buy |
6,247
+1,517
| +32% | +$65.8K | ﹤0.01% | 1737 |
|
|
2020
Q3 | $203K | Buy |
4,730
+556
| +13% | +$23.9K | ﹤0.01% | 1763 |
|
|
2020
Q2 | $195K | Buy |
+4,174
| New | +$195K | ﹤0.01% | 1811 |
|